MED

Medifast, Inc. [MED] Stock Forecast

Q: What is Medifast, Inc. stock symbol ?

Medifast, Inc. is a US stock, located in Owings mills of Maryland and trading under the symbol MED

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

Stock Summary

Earnings have grown 63.25% per last year.

Earnings are expected to rise 24.41% next year

EPS has been increasing for the past 3 years (Yearly statements)

MED's dividend payments are well covered by cash flows with cash payout ratio of 44.52%.

Profit margins (0.09%) are lower than the previous year (0.11%)

MED has less than 1 year of cash runway

An RSI reading of 30 or below indicates an oversold or undervalued condition.

Top Correlated Resources

MED

Top 10 Correlated ETFs

MED

Top 10 Correlated Stocks

MED

In the News

09:23 25 Sep 2022 MED

My Top 10 Dividend Payers For September

Dividends are an important source of income for investors of all types but especially those that rely on their investments in retirement. My ideal dividend payer accomplishes four goals: maximize total return, deliver a meaningful yield, experience strong growth, and provide a margin of safety.

04:14 25 Sep 2022 MED

7 Dividend Stocks to Buy and Hold Forever

If you're looking for dividend stocks to buy and hold forever, a good place to start is companies that have done an excellent job increasing their dividends and are expected to keep doing so in the future. While the first place to look for such names should logically be a list of S&P 500 Dividend Aristocrats, I widened the search to the S&P 1500.

09:03 25 Sep 2022 MED

Losing Weight Is Losing Ground in the Stock Market

Weight-loss and nutrition companies have lost half or more of their value in the past year despite expectations of a postpandemic boom.

03:09 25 Sep 2022 MED

Medifast: Would Chuck Akre Approve?

It is a consistently profitable growth company that was recognized by Fortune and Forbes several times. Yet, the stock has crashed over 64% since it peaked on 1st May 2021, falling from $332.25 to $119.05 as of 2 September 2022.

09:47 25 Sep 2022 MED

Medifast (MED) Down More Than 20% in 3 Months on Cost Woes

Medifast (MED) has been seeing high SG&A expenses and escalated raw material costs. The company expects short-term margin pressure in 2022 due to inflation and continued investments.

01:26 25 Sep 2022 MED

Medifast: Let's Dive Into Its Q2 Earnings And Assess The Bad And The Good

Medifast's stock plummeted 16% after reporting Q2 earnings. Both earnings and revenue beat analysts' consensus but guidance was cut significantly.

02:18 25 Sep 2022 MED

Medifast (MED) Q2 Earnings Top Estimates, Guidance Lowered

Medifast's (MED) second-quarter 2022 results reflect increased active earning OPTAVIA Coaches and elevated costs. Management cuts guidance for 2022 due to inflation.

11:27 25 Sep 2022 MED

Medifast, Inc. (MED) CEO Dan Chard on Q2 2022 Results - Earnings Call Transcript

Medifast, Inc. (NYSE:MED ) Q2 2022 Earnings Conference Call August 3, 2022 4:30 PM ET Company Participants Reed Anderson - ICR, Investor Relations Dan Chard - Chairman & Chief Executive Officer Jim Maloney - Chief Financial Officer Conference Call Participants Chris Neamonitis - Jefferies Operator Good afternoon. And welcome to Medifast Second Quarter 2022 Earnings Conference Call.

09:16 25 Sep 2022 MED

Explore DuPont Analysis & Pick 5 Top Stocks

Do you have more faith in DuPont analysis than simple ROE calculation? Tap UFP Industries (UFPI), MEDIFAST (MED), Skyline (SKY), Hudson Global (HSON) and Expeditors International of Washington (EXPD).

06:39 25 Sep 2022 MED

Dive Into DuPont Analysis & Pick 5 Top Stocks

Do you have more faith in DuPont analysis than simple ROE calculation? Tap Sanderson Farms (SAFM), MEDIFAST (MED), Skyline (SKY), Hudson Global (HSON) and Expeditors International of Washington (EXPD).

Financial details

Company Rating

Strong Buy

Market Cap

1.31B

Income

156.9M

Revenue

1.66B

Book val./share

11.4

Cash/share

5.38

Dividend

6.34

Dividend %

5.64%

Employees

984

Optionable

Shortable

Yes

Earnings

02 Nov 2022

P/E

8.34

Forward P/E

8.71

PEG

1.51

P/S

0.77

P/B

9.86

P/C

20.89

P/FCF

18.79

Quick Ratio

0.32

Current Ratio

1.29

Debt / Equity

0.18

LT Debt / Equity

0.18

EPS (TTM)

13.56

EPS next Y

12.9

EPS next Q

2.51

EPS this Y

60.52%

EPS next Y

-4.87%

EPS next 5Y

-4.87%

EPS last 5Y

43.32%

Revenue last 5Y

38.31%

Revenue Q/Q

8.56%

EPS Q/Q

-4.97%

SMA20

-13.53%

SMA50

-33.72%

SMA100

-35.09%

Inst Own

82.17%

Inst Trans

-1.39%

ROA

46%

ROE

84%

ROC

1.35%

Gross Margin

73%

Oper. Margin

12%

Profit Margin

Payout

46%

Shs Outstand

11.02M

Shs Float

9.99M

Target Price

52W Range

116.5-235.71

52W High

-52.17%

52W Low

-3.11%

RSI

Rel Volume

0.6

Avg Volume

190.01K

Volume

114.22K

Perf Week

-6.99%

Perf Month

-14.87%

Perf Quarter

-36.27%

Perf Half Y

-35.85%

Beta

1.19297

Volatility

2.92%, 8.97%

Prev Close

-1.77%

Price

112.39

Change

-1.78%

Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31
Revenue per share	25.29	41.94	60.63	79.42	130.52
Net income per share	2.32	4.67	6.62	8.74	14.03
Operating cash flow per share	3.63	5.09	7.16	12.34	8.09
Free cash flow per share	3.35	4.68	6.3	11.83	5.16
Cash per share	8.29	8.46	7.87	14.82	9.37
Book value per share	9.11	9.13	8.91	13.36	17.32
Tangible book value per share	9.11	9.13	8.91	13.36	17.32
Share holders equity per share	9.11	9.13	8.91	13.36	17.32
Interest debt per share	0	0	0	0.17	2.78
Market cap	837.18M	1.49B	1.16B	2.76B	2.24B
Enterprise value	762.11M	1.41B	1.08B	2.6B	2.17B
P/E ratio	30.2	26.78	14.84	26.86	13.67
Price to sales ratio	2.78	2.98	1.62	2.95	1.47
POCF ratio	19.36	24.57	13.73	19.02	23.71
PFCF ratio	20.93	26.74	15.59	19.83	37.16
P/B Ratio	7.71	13.69	11.03	17.57	11.07
PTB ratio	7.71	13.69	11.03	17.57	11.07
EV to sales	2.53	2.82	1.51	2.78	1.42
Enterprise value over EBITDA	17.11	18.84	11.13	18.37	9.73
EV to operating cash flow	17.63	23.23	12.81	17.91	22.96
EV to free cash flow	19.06	25.28	14.55	18.67	35.97
Earnings yield	0.03	0.04	0.07	0.04	0.07
Free cash flow yield	0.05	0.04	0.06	0.05	0.03
Debt to equity	0	0	0	0	0.13
Debt to assets	0.26	0.36	0.46	0.43	0.49
Net debt to EBITDA	-1.69	-1.09	-0.79	-1.14	-0.32
Current ratio	3.37	2.41	1.94	2.1	1.81
Interest coverage	0	0	0	0	0
Income quality	1.56	1.09	1.08	1.41	0.58
Dividend Yield	0.02	0.02	0.03	0.02	0.03
Payout ratio	0.56	0.42	0.45	0.52	0.39
Sales general and administrative to revenue	0	0	0	0.6	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0	0	0	0	0
Capex to operating cash flow	-0.07	-0.08	-0.12	-0.04	-0.36
Capex to revenue	-0.01	-0.01	-0.01	-0.01	-0.02
Capex to depreciation	-0.77	-1.11	-2.18	-0.81	-5.02
Stock based compensation to revenue	0.01	0.01	0.01	0.01	0.01
Graham number	21.82	30.98	36.42	51.25	73.93
ROIC	0.36	0.63	0.79	0.81	0.95
Return on tangible assets	0.19	0.33	0.4	0.37	0.41
Graham Net	6	5.1	2.41	7.03	0.32
Working capital	88.06M	85.2M	74.76M	122.96M	137.03M
Tangible asset value	0	0	0	0	0
Net current asset value	87.85M	85.2M	64.33M	115.48M	111.01M
Invested capital	0	0	0	0.01	0.16
Average receivables	580K	797.5K	1.01M	584K	0
Average payables	25.96M	28.79M	29.19M	35.77M	53.33M
Average inventory	36.36M	46.14M	51.08M	53.39M	116.72M
Days sales outstanding	0.7	0.74	0.73	0.23	0
Days payables outstanding	79.92	65.75	46.67	55.08	64.94
Days of inventory on hand	95.66	117.21	100.68	82.22	164.91
Receivables turnover	523.55	495.55	496.64	1.6K	0
Payables turnover	4.57	5.55	7.82	6.63	5.62
Inventory turnover	3.82	3.11	3.63	4.44	2.21
ROE	0.26	0.51	0.74	0.65	0.81
Capex per share	-0.27	-0.41	-0.85	-0.5	-2.93

Quarterly Fundamentals Overview

Last date of statement is 2022-06-30 for Q2

Metric	2021-06-30	2021-09-30	2021-12-31	2022-03-31	2022-06-30
Revenue per share	33.54	35.36	32.32	36.13	39.93
Net income per share	4	3.59	2.91	3.62	3.44
Operating cash flow per share	1.78	1.35	-0.64	3.78	3.85
Free cash flow per share	1.13	0.46	-1.63	3.52	3.6
Cash per share	16.8	13.68	9.37	10.56	5.38
Book value per share	16.57	16.78	17.32	18.69	11.4
Tangible book value per share	16.57	16.78	17.32	18.69	11.4
Share holders equity per share	16.57	16.78	17.32	18.69	11.4
Interest debt per share	1.75	1.68	2.78	2.68	4.97
Market cap	3.33B	2.25B	2.45B	1.97B	2.05B
Enterprise value	3.15B	2.12B	2.38B	1.89B	2.04B
P/E ratio	17.7	13.41	17.99	11.81	13.1
Price to sales ratio	8.44	5.45	6.48	4.73	4.52
POCF ratio	159.3	142.55	-328.28	45.19	46.83
PFCF ratio	250.44	416.25	-128.32	48.54	50.08
P/B Ratio	17.08	11.48	12.09	9.14	15.83
PTB ratio	17.08	11.48	12.09	9.14	15.83
EV to sales	8	5.12	6.29	4.52	4.51
Enterprise value over EBITDA	49.31	36.62	51.35	32.91	39.56
EV to operating cash flow	151.09	134.02	-318.68	43.2	46.72
EV to free cash flow	237.53	391.32	-124.56	46.4	49.97
Earnings yield	0.01	0.02	0.01	0.02	0.02
Free cash flow yield	0	0	-0.01	0.02	0.02
Debt to equity	0.08	0.07	0.13	0.11	0.18
Debt to assets	0.47	0.47	0.49	0.49	0.62
Net debt to EBITDA	-2.68	-2.33	-1.55	-1.52	-0.09
Current ratio	1.98	1.87	1.81	1.79	1.29
Interest coverage	0	0	0	-579.86	298.56
Income quality	0.44	0.38	-0.22	1.05	1.12
Dividend Yield	0.01	0.01	0.01	0.01	0.01
Payout ratio	0.36	0.4	0.5	0.4	0.48
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0	0	0	0	0
Capex to operating cash flow	-0.36	-0.66	1.56	-0.07	-0.06
Capex to revenue	-0.02	-0.03	-0.03	-0.01	-0.01
Capex to depreciation	-2.89	-3.94	25.11	-1.23	-1.04
Stock based compensation to revenue	0.01	0.01	0.01	0.01	0.01
Graham number	38.59	36.82	33.67	38.99	29.73
ROIC	0.29	0.26	0.2	0.23	0.32
Return on tangible assets	0.13	0.11	0.09	0.1	0.11
Graham Net	6.45	4.24	0.32	0.96	-6.3
Working capital	150.34M	140.14M	137.03M	143.23M	55.14M
Tangible asset value	0	0	0	0	0
Net current asset value	134.78M	125.92M	111.01M	118.85M	32.23M
Invested capital	0.11	0.1	0.16	0.14	0.43
Average receivables	0	0	0	0	0
Average payables	0	0	0	0	0
Average inventory	142.38M	159.29M	184.51M	188.97M	172.97M
Days sales outstanding	0	0	0	0	0
Days payables outstanding	0	0	64.09	0	105.81
Days of inventory on hand	85.8	109.7	162.77	147.49	107.31
Receivables turnover	0	0	0	0	0
Payables turnover	0	0	1.4	0	0.85
Inventory turnover	1.05	0.82	0.55	0.61	0.84
ROE	0.24	0.21	0.17	0.19	0.3
Capex per share	-0.65	-0.89	-0.99	-0.26	-0.25

Frequently Asked Questions

What is Medifast, Inc. stock symbol ?

Medifast, Inc. is a US stock , located in Owings mills of Maryland and trading under the symbol MED

What is Medifast, Inc. stock quote today ?

Medifast, Inc. stock price is $112.39 today.

Is Medifast, Inc. stock public?

Yes, Medifast, Inc. is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 190.01K
Market Capitalization 1.31B
Employee 984
CEO Mr. Daniel Chard
Headquarters Owings Mills,MARYLAND,US
IPO Date 1993-12-30
Website https://medifastinc.com

Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is headquartered in Baltimore, Maryland.